Current management of childhood acute myeloid leukemia
JE Rubnitz - Pediatric Drugs, 2017 - Springer
The outcome for children with acute myeloid leukemia (AML) has improved significantly over
the past 30 years, with complete remission and overall survival rates exceeding 90 and …
the past 30 years, with complete remission and overall survival rates exceeding 90 and …
Current Management of Childhood Acute Myeloid Leukemia
JE Rubnitz - Pediatric Drugs, 2017 - search.proquest.com
Abstract Published online: 27 October 2016© Springer International Publishing Switzerland
2016 Abstract The outcome for children with acute myeloid leukemia (AML) has improved …
2016 Abstract The outcome for children with acute myeloid leukemia (AML) has improved …
Current Management of Childhood Acute Myeloid Leukemia
JE Rubnitz - Paediatric drugs, 2017 - pubmed.ncbi.nlm.nih.gov
The outcome for children with acute myeloid leukemia (AML) has improved significantly over
the past 30 years, with complete remission and overall survival rates exceeding 90 and …
the past 30 years, with complete remission and overall survival rates exceeding 90 and …
Current Management of Childhood Acute Myeloid Leukemia
JE Rubnitz - Pediatric Drugs, 2016 - infona.pl
The outcome for children with acute myeloid leukemia (AML) has improved significantly over
the past 30 years, with complete remission and overall survival rates exceeding 90 and …
the past 30 years, with complete remission and overall survival rates exceeding 90 and …
Current Management of Childhood Acute Myeloid Leukemia.
JE Rubnitz - Paediatric Drugs, 2017 - europepmc.org
The outcome for children with acute myeloid leukemia (AML) has improved significantly over
the past 30 years, with complete remission and overall survival rates exceeding 90 and …
the past 30 years, with complete remission and overall survival rates exceeding 90 and …